We are hiring! Click to View Open Positions.

Posters

November 2022

Poster Hall

SRK-181, a latent TGFβ1 inhibitor: safety, efficacy, and biomarker results from the dose escalation portion of a phase I trial (DRAGON trial) in patients with advanced solid tumors

View This Poster

October 2022

International Scientific Congress on SMA

Apitegromab in SMA: Efficacy, Safety and PK/PD Assessments in 24 Months of TOPAZ

View This Poster

October 2022

WMS Hybrid Congress

Apitegromab in SMA: An analysis of multiple efficacy endpoints in the TOPAZ extension study (P.102)

View This Poster

September 2022

12th Annual World Clinical Biomarkers & CDx Summit

Development of a Comprehensive Biomarker Strategy for the Latent TGFβ1 Inhibitor SRK-181 Phase 1 Clinical Trial, DRAGON

View This Poster

September 2022

American College of Clinical Pharmacology Annual Meeting

Preliminary Population Pharmacokinetic Modeling of SRK-181 from Phase 1 Dose Escalation Study

View This Poster

July 2022

Federation of American Societies for Experimental Biology

Selective Targeting of Matrix-Associated TGFβ1 is an Attractive Approach for Anti-Fibrotic Therapy

View This Poster